Association of Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and State-Issued Nonpharmaceutical Interventions: United States, 1 August 2020 to 30 March 2021.

导出 OA

翻译打印收藏纠错

作者： Maureen J,Miller ^[1] ; Austin,Himschoot ^[2] ; Natalie,Fitch ^[2] ; Sucheta,Jawalkar ^[2] ; Dane,Freeman ^[2] ; Charity,Hilton ^[2] ; Kevin,Berney ^[3] ; Gery P,Guy ^[1] ; Tina J,Benoit ^[1] ; Kristie E N,Clarke ^[1] ; Michael P,Busch ^[4] ; Jean D,Opsomer ^[5] ; Susan L,Stramer ^[6] ; Aron J,Hall ^[1] ; Adi V,Gundlapalli ^[1] ; Adam,MacNeil ^[1] ; Russell,McCord ^[1] ; Gregory,Sunshine ^[1] ; Mara,Howard-Williams ^[1] ; Christopher,Dunphy ^[1] ; Jefferson M,Jones ^[1]

作者单位： CDC COVID-19 Response, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA. ^[1] Georgia Tech Research Institute, Atlanta, Georgia, USA. ^[2] Geospatial Research, Analysis, and Services Program (GRASP), Agency for Toxic Substances and Disease Registry, CDC, Atlanta, Georgia, USA. ^[3] Vitalant Research Institute, San Francisco, California, USA. ^[4] Westat, Inc, Rockville, Maryland, USA. ^[5] Scientific Affairs, American Red Cross, Gaithersburg, Maryland, USA. ^[6]

关键词 COVID-19 SARS-CoV-2 nonpharmaceutical interventions novel coronavirus seroprevalence

主题词抗体, 病毒(Antibodies, Viral);人类(Humans);血清流行病学研究(Seroepidemiologic Studies);美国(United States)

DOI 10.1093/cid/ciac469

PMID 35684974

发布时间 2023-01-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交